1454-P: Food Insecurity in People with Type 1 Diabetes and Glycemic Outcomes

Abstract

Background: This multi-center study aims to explore relationships between individuals with type 1 diabetes (T1D) who are at risk for food insecurity and glycemic outcomes. Methods: Electronic health record data from T1D Exchange Quality Improvement Collaborative (T1DX-QI) categorized completed Hunger Vital Signs (HVS) questionnaires into at risk and no risk for food insecurity. At-risk individuals were defined as selecting “often true” or “sometimes true” to screening questions, whereas primary outcome was recent A1c levels. Demographic information and diabetes related covariates were assessed for potential relationships. Results: In the total T1D cohort (N=4453), 3.8% were at risk for food insecurity. Stratifying by age, 6% of youth (<18 years) and 5% of adults (>18 years) were at risk. Statistically significant differences were observed among food insecurity risk and insurance type. Of those at risk, 54% had public insurance compared with 7% private. Individuals at risk had a higher mean HbA1c when compared with individuals not at risk (9.4% vs 8.5% respectively, p<.001). The odds of an individual having an HbA1c >7% were higher in the group at risk relative to the group not at risk OR1.4 (95% CI 0.9, 2.1). Conclusion: Individuals in this population who were at risk for food insecurity also had elevated A1c levels. Interventions are needed to identify effective ways of improving food insecurity among people with T1D. Disclosure E.L.Ospelt: None. V.Raman: None. B.Seyoum: None. O.Ebekozien: Advisory Panel; Medtronic, Research Support; Eli Lilly and Company, Dexcom, Inc. N.Noor: None. J.Haw: None. S.Hsieh: None. R.S.Weinstock: Consultant; Jaeb Center for Health Research, Other Relationship; Wolters Kluwer Health, Research Support; Insulet Corporation, Medtronic, Eli Lilly and Company, Novo Nordisk, Boehringer Ingelheim Inc., Hemsley Charitable Trust, National Institute of Diabetes and Digestive and Kidney Diseases, Tandem Diabetes Care, Inc., Kowa Pharmaceuticals America, Inc. D.W.Hansen: Research Support; 3Boehringer Ingelheim Canada Ltd./Ltée, Lilly, Insulet Corporation, T1D Exchange, Medtronic. K.Cossen: None. K.Fantasia: None. I.Guttmann-bauman: None. Funding The Leona M. and Harry B. Helmsley Charitable Trust